Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Journal of Visualized Experiments · 2023-05-12 · (195)
DOI: 10.3791/63744 ↗At a glance
Video/Audio in Journal of Visualized Experiments, published online on 2023-05-12. Written by Alice Usai and 4 co-authors. Institution: Department of Biology, University of Pisa; alice.usai@biologia.unipi.it. Major MEDLINE topics: Zebrafish, Pancreatic Neoplasms. Cited 2 times so far (Crossref); 23 references.
Abstract (original language)
Cancer is one of the main causes of death worldwide, and the incidence of many types of cancer continues to increase. Much progress has been made in terms of screening, prevention, and treatment; however, preclinical models that predict the chemosensitivity profile of cancer patients are still lacking. To fill this gap, an in vivo patient-derived xenograft model was developed and validated. The model was based on zebrafish (Danio rerio) embryos at 2 days post fertilization, which were used as recipients of xenograft fragments of tumor tissue taken from a patient's surgical specimen. It is also worth noting that bioptic samples were not digested or disaggregated, in order to maintain the tumor microenvironment, which is crucial in terms of analyzing tumor behavior and the response to therapy. The protocol details a method for establishing zebrafish-based patient-derived xenografts (zPDXs) from primary solid tumor surgical resection. After screening by an anatomopathologist, the specimen is dissected using a scalpel blade. Necrotic tissue, vessels, or fatty tissue are removed and then chopped into 0.3 mm x 0.3 mm x 0.3 mm pieces. The pieces are then fluorescently labeled and xenotransplanted into the perivitelline space of zebrafish embryos. A large number of embryos can be processed at a low cost, enabling high-throughput in vivo analyses of the chemosensitivity of zPDXs to multiple anticancer drugs. Confocal images are routinely acquired to detect and quantify the apoptotic levels induced by chemotherapy treatment compared to the control group. The xenograft procedure has a significant time advantage, since it can be completed in a single day, providing a reasonable time window to carry out a therapeutic screening for co-clinical trials.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Biology, University of Pisa; alice.usai@biologia.unipi.it.
- General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa.
- Department of Biology, University of Pisa.
Cite
APA
Usai, A., Di Franco, G., Gabellini, C., Morelli, L., & Raffa, V. (2023). Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing. Journal of Visualized Experiments. https://doi.org/10.3791/63744
Vancouver
Usai A, Di Franco G, Gabellini C, Morelli L, Raffa V. Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing. Journal of Visualized Experiments. 2023. doi:10.3791/63744
BibTeX
@article{Usai2023,
author = {Usai, Alice and Di Franco, Gregorio and Gabellini, Chiara and Morelli, Luca and Raffa, Vittoria},
title = {Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing},
journal = {Journal of Visualized Experiments},
year = {2023},
number = {195},
doi = {10.3791/63744}
}
EUVIMED